drugset
drugset / Trial / NCT04900415

Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction

NCT04900415 ↗

Phase 2 Unknown 25 enrolled Ivan FN Hung MD Pamela Youde Nethersole Eastern Hospital · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

A combination of oral vitamin A (VitA) and intense aromatic chemosensory smell training (ST) by pulse aromatic stimulation will expedite the neurosensory recovery of olfaction in patients suffering from prolonged COVID-19-related olfactory dysfunction (OD).

Timeline

Start
2020-07-22
Primary completion
2021-03-12
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin A Unknown 7500 ug Oral

Indications

COVID-19